observed that CLDN2 can promote liver metastasis of colorectal cancer and that CLDN2 in colorectal cancer patient-derived extracellular vesicles can be used as a prognostic biomarker to predict the occurrence of surrogate liver metastases in colorectal cancer patients [75]. Here, CLDN2 is linked to colorectal cancer.